Journals / Ulusal Cerrahi Dergisi / 2016 / Cilt: 32 - Sayı: 1

Primary thyroid lymphoma

Primer tiroid lenfoması

Pages
92–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, three cases with primary thyroid lymphoma in which three different treatment modalities have been applied are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary thyroid lymphoma is an uncommon thyroid malignancy.
📊
Key Findings & Data:The treatment modalities significantly differ from other thyroid malignancies.
💡
Conclusion & Impact:In this report, three cases with primary thyroid lymphoma in which three different treatment modalities have been applied are presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Primary thyroid lymphoma is an uncommon thyroid malignancy. The treatment modalities significantly differ from other thyroid malignancies. Frequently it is accompanied by Hashimoto thyroiditis, and it may be difficult to differentiate the two entities histologically. Patients typically present with suddenly growing mass in the thyroid gland. Discrimination between primary and secondary lymphoma is important due to variations in diagnostic tools, treatment modalities and prognosis. Surgery, chemotherapy, radiotherapy or combinations of these modalities may be applied in treatment. In this report, three cases with primary thyroid lymphoma in which three different treatment modalities have been applied are presented.

Özet

Primer tiroid lenfoması nadir görülen tiroid malignitelerindendir. Tedavileri diğer tiroid malignitelerinden belirgin farklılık gösterir. Sıklıkla Hashimoto tiroiditi ile birlikte bulunur ve histolojik olarak ayırt etmek güç olabilir. Hastalar tipik olarak tiroitte hızlı büyüyen kitle şikayeti ile başvurur. Primer - sekonder lenfoma ayrımı tanı, tedavi ve prognozdaki değişkenler nedeni ile önemlidir. Tedavide cerrahi, kemoterapi, radyoterapi veya kombinasyonları kullanılabilir. Bu çalışmada farklı tedavi seçenekleri uygulanmış üç olgu sunulmuştur.

🔖

Cite This Article

DÜNDAR, H. Z., SARKUT, P., KIRDAK, T., KORUN, N. (2016). Primary thyroid lymphoma. Ulusal Cerrahi Dergisi, Cilt: 32 - Sayı: 1, 92–94. https://ajindex.com/articles/325367

References (2)

  1. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996; 28: 25-32. [CrossRef] Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604. [CrossRef] Katna R, Shet T, Sengar M, Menon H, Laskar S, Prabhash K, et al. Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center. Head Neck 2013; 35: 165-171. [CrossRef] Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, Ka- meyama K, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long term study involving 24553 patients with Hashimoto's disease. Br J Haematol 2011; 153: 236- 243. [CrossRef] Morgen EK, Geddie W, Boerner S, Bailey D, Santos Gda C. The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: A retrospective study of nine cases and review of published series. J Clin Pathol 2010; 63: 129-133. [CrossRef] Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Re- port of the Committee on Hodgkin's Disease Staging Classificati- on. Cancer Res 1971; 31: 1860-1861.
  2. Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) significantly improves the outcome for pa- tients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of German low-grade lymphoma study group. Blood 2005; 106: 3725-3732. [CrossRef] Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prog- nosis of primary thyroid lymphoma: Demographic, clinical and pathologic predictors of survival in 1408 cases. Surgery 2009; 146: 1105-1115. [CrossRef] Onal C, Li YX, Miller RC, Poortmans P, Constantinu N, Weber DC, et al. Treatment results and prognostic factors in primary thyro- id lymphoma patients: a rare cancer network study. Ann Oncol 2011; 22: 156-164.[CrossRef] 77